Hip Reconstruction Devices Market

Hip Reconstruction Devices Market Outlook (2023-2033)

Expanding at a steady CAGR of 4%, the global hip reconstruction devices market is valued at US$ 8.21 billion in 2023 and is projected to reach US$ 12.15 billion by the year 2033.

Hip reconstruction devices are bifurcated into primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices, and hip resurfacing devices. Sales of primary hip reconstruction devices are expected to progress at a CAGR of 4.5% during the forecast period.

Primary hip reconstruction is a clinical intervention where a primary joint replacement procedure is carried out on the specific injured joint of the patient. A damaged or worn-out hip joint is replaced using implants made of metal, high-density polyethylene, or ceramic during a primary hip replacement surgery.

Hip arthroplasty has become a common operation due to the high prevalence of hip disease and the widespread success of hip replacement surgeries. The hip prosthesis can be simply categorized into unipolar, bipolar, and complete arthroplasties.

Global demand for partial hip reconstruction devices is predicted to evolve at a CAGR of 3% during the next 10 years. An orthopedic operation called a partial hip replacement or hip hemiarthroplasty involves removing and replacing the femoral head to cure certain femoral neck fractures.

Similar to a total hip replacement, the femoral stem is placed and can either be cemented or not. If the acetabulum is still in good shape, there is no interference made. In a hospital or surgical facility, the majority of partial hip replacement procedures can be performed within an hour.

A hip replacement, also known as hip arthroplasty is a surgical treatment to treat severe hip pain or injuries. Through surgery, artificial implants are used to replace some of the hip joints. A ball (located at the head of the femur, popularly called the thigh bone), and a socket, (make up the hip joint/hip bone). Either one or both components may be replaced during hip replacement surgery. The treatment aims to lessen the patient's pain enough to resume everyday activities and exercise.

The prevalence of osteoarthritis is increasing rapidly across the world. Hip arthroplasty is performed to treat osteoarthritis. The rapidly increasing rate of the ageing population, strong government assistance, favourable pricing trends, and improved patient understanding of replacement surgeries are all boosting sales of hip replacement devices.

Report Attributes	Details
Hip Reconstruction Devices Market Size (2023E)	US$ 8.21 Billion
Forecasted Market Value (2033F)	US$ 12.15 Billion
Global Market Growth Rate (2023-2033)	4% CAGR
Canada Market Growth Rate (2023-2033)	3% CAGR
China Market Growth Rate (2023-2033)	7% CAGR
Japan Market Growth Rate (2023-2033)	2% CAGR
Germany Market Growth Rate (2023-2033)	2.5% CAGR
Key Companies Profiled	B. Braun Melsungen AG Corin Group PLC DePuy Synthes Exactech, Inc. MicroPort Scientific Corporation Smith & Nephew PLC Stryker Corporation United Orthopedic Corporation Waldemar Link GmbH & Co. KG Zimmer Biomet Holdings, Inc.

Which New Developments are Boosting the Demand for Hip Reconstruction Devices?

“Increasing Awareness Regarding Hip Reconstruction Procedures”

The use of technologically advanced hip replacement tools for patients who undergo hip surgeries is one of the major trends driving the growth of the hip reconstruction devices market. In recent years, people have begun turning to digital tools and online services to learn more about particular ailments. One such area is joint replacement, where various online applications have been introduced to assist patients during surgeries, facilitate communication with orthopedic physicians, and provide post-surgery info.

• For instance, the BMC Journal published an article about the RECOVER-E mobile app that is being developed to aid patients recovering from knee and hip operations.

Various initiatives are being quickly scaled up by healthcare organizations, and it is predicted that potential opportunities in the hip reconstruction devices market will be generated due to increasing consumer knowledge of online resources and computer-assisted surgeries.

• Furthermore, Meitra Hospital Kozhikode announced the introduction of robotic joint replacement surgeries in August 2021. It is a significant step toward the introduction of cutting-edge technology that will assure a complete and quick recovery for patients who need joint replacement surgeries. Meitra is the first and sole training center for performing robotic arthroplasty (joint replacement surgery) in India owing to the CORI-Robotic Joint Replacement Surgical System, which equips the facility to perform all types of total or partial hip and knee replacement surgeries.

“Supportive Healthcare Reimbursement Policies”

Global demand for hip implants is increasing as a result of adequate health coverage and changes to the health reimbursement policies for joint replacement surgeries. The respective governments of several nations have introduced various health reimbursement programs for joint replacement surgeries to offer everyone access to inexpensive and high-quality care. This is positively influencing the demand for orthopedic implants.

“Rapidly Increasing Adoption of Customized Hip Implants”

The demand for orthopedic replacement devices is rising with the increasing need for specially designed implants for both men and women. The sizes of implants vary since each patient's anatomy is different. For patient-specific implants, several manufacturers are putting their attention on 3D printing technologies.

An enormous increase in custom implants was brought about by the adoption of 3D printing technologies in the production of orthopedic devices. The hip reconstruction devices market is projected to benefit from the numerous orthopedic firms creating cutting-edge technologies that can be leveraged to produce technologically advanced replacement prostheses.

“Increasing Senior Population across the World”

According to a WHO report,

• One in six people around the globe will be 60 or older by 2030. By this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020.
• The population across the globe who are 60 or older will double (2.1 billion) by 2050. Between 2020 and 2050, the population of individuals 80 or older is projected to triple, reaching 426 million.

With this seeming rise in the population of elderly people, the healthcare sector is thriving, especially in industrialized nations, and hip replacement is one field that is doing particularly well.

• According to the National Institute of Health (NIH), geriatrics is particularly susceptible to hip abnormalities, and almost a million hip operations are carried out annually.

Senior people are more prone to hip fractures due to several orthopedic and trauma problems, this increases the rate of hip construction surgeries and demand for hip surgical devices. Thus all the above aspects are showing positive growth in the sales of hip reconstruction devices.

Why is Hip Reconstruction Device Sales Growth Being Hampered?

“Product Recalls and Several Side Effects”

The incidence of hip reconstruction surgeries is increasing rapidly. However, the risks associated with implant use are a significant issue that may limit the sales of joint reconstruction devices in the coming years. According to several claims, patients had severe side effects as a result of the device’s flaws. Allergies, metal poisoning, infections, and bone resorption are among the linked adverse effects.

Major companies in the hip reconstruction market such as Zimmer Biomet have been subject to numerous individual and class action lawsuits, due to the failure of their orthopedic replacement devices. There were around 2,000 Stryker replacement cases in state and federal courts in the U.S. as of August 2019.

Additionally, it is predicted that sales growth over the coming years would be hampered by the large product recalls of hip and knee replacement devices for major manufacturers worldwide.

• For instance, from 2003 to 2019, there were over 13,000 recalls of knee replacement systems and components, according to the U.S. FDA. The most recalls were issued for Zimmer Biomet products, followed by Johnson & Johnson Services Inc. and Smith & Nephew.

Country-wise Analysis

What Allows the U.S. to Be a Dominant Market for Hip Reconstruction Devices?

“Increasing Senior Population and Presence of Leading Hip Reconstruction Device Manufacturers”

The United States is currently dominating the North American hip reconstruction devices market. This dominance can be attributed to the factors such as the rising rate of the senior population in the nation, the high prevalence of hip fractures and arthritis, and the presence of well-established healthcare infrastructure and key market players.

Additional factors anticipated to boost market growth include advantageous government healthcare policies and the rising number of research partnerships.

Which European Countries are Leading Markets for Hip Reconstruction Devices?

“High Rate of Hip Replacement Surgeries Performed in Switzerland & Germany”

The Europe hip reconstruction devices market is being fuelled by the rising rate of patients living from osteoarthritis and other bone problems as well as strategic moves made by major industry players, such as mergers and acquisitions, in the region. The sales growth is also anticipated to be aided by the increasing use of technologically advanced tools, product type diversification, and standard regulatory approvals for surgical products.

• According to the Organization for Economic Cooperation and Development, the number of hip replacement surgeries per 100,000 people in nations such as Switzerland, Germany, Italy, and France is 308, 299, 172, and 241, respectively, which are indicating the rising demand for hip implants.

Demand for hip reconstruction devices in Germany is predicted to expand at a CAGR of 2.5% from 2023 to 2033. The rising cases of hip injuries and growing demand for customized implants are driving sales growth in the nation.

What is Driving the Sales of Hip Reconstruction Devices in China & Japan?

“Supportive Government Approach and Launch of Advanced Devices”

The Asia Pacific market is predicted to expand at the fastest rate throughout the projection period. Improvements in bone scan diagnoses for detecting bone density among laboratory testing, greater reimbursements by commercial and governmental organizations, and the rapidly growing healthcare infrastructure are boosting sales of orthopedic implants.

Favourable policies by respective governments to support orthopedic operations are also boosting product demand in Asian nations including China, Japan, South Korea, and India.

• For instance, the government of China's volume-based procurement approach, introduced in 2018, has made medical items such as implants very affordable in the nation, mainly through better supply chain management.
• Sep 2022: Smith + Nephew, a U.K.-based company, has made its OR3O Dual Mobility System available in Japan for use in primary and revision hip arthroplasty (hip joint replacement surgery). Dual mobility implants, as opposed to conventional options, have a small diameter femoral head that locks into a larger polyethylene insert, enhancing stability, lowering the risk of dislocation, and providing a wider range of motion.

It is projected that such actions with better product standards and adherence to safety regulations in respective nations are boosting the sales of orthopedic devices.

Category-wise Analysis

Which Material Type Implant is Most Widely Preferred?

“Metal-on-polythene Material Implants are Cost-effective & Durable”

As the least expensive and most durable/long-lasting implant material type, metal-on-polythene, also known as metal-on-plastic material, is currently dominating the sales growth. Because it lessens the likelihood of metal breaking, this kind of implant is also referred to as the safest compared to others. Currently, scientists are attempting to make them even more resilient, encouraging product demand.

The ceramic-on-polyethylene material type is anticipated to have substantial growth during the projection period due to its popularity as one of the implants used in ceramic hip replacement procedures. The older ceramic models were susceptible to simple cracking. However, the recently introduced advanced ceramic implant models are significantly more durable and do not break as easily; they go through rigorous quality control testing.

Competitive Landscape

Global leaders in terms of market revenue are Zimmer Biomet, DePuy Synthes, and Stryker Corporation. Zimmer Biomet holds the largest market share due to increasing sales of its hip implants. On the other side, DePuy Synthes and Stryker are in the top positions as a result of their strong sales forces, superior local supply capabilities, and attention to both organic and inorganic growth strategies.

• The ROSA Hip System for robotically-assisted direct anterior total hip replacement has been approved by the U.S. Food and Drug Administration (FDA), according to a statement issued by Zimmer Biomet Holdings, Inc. in August 2021.

Segmentation of Hip Reconstruction Devices Industry Research

• By Indication :

  • Osteoarthritis
  • Rheumatoid Arthritis
  • Trauma

• By Product :

  • Primary Hip Reconstruction Devices
  • Partial Hip Reconstruction Devices
  • Revision Hip Reconstruction Devices
  • Hip Resurfacing Devices

• By Material :

  • Metal-on-metal
  • Metal-on-polyethylene
  • Ceramic-on-polyethylene
  • Ceramic-on-metal
  • Ceramic-on-ceramic

• By End User :

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA